"Calcifediol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
| Descriptor ID |
D002112
|
| MeSH Number(s) |
D04.210.500.247.222.159.478.250 D04.210.500.247.808.146.478.250 D04.210.500.812.768.196.478.250 D10.570.938.146.478.250
|
| Concept/Terms |
Calcifediol- Calcifediol
- 25-Hydroxyvitamin D 3
- 25 Hydroxyvitamin D 3
- 25-Hydroxycholecalciferol Monohydrate
- 25 Hydroxycholecalciferol Monohydrate
- Monohydrate, 25-Hydroxycholecalciferol
- 25-Hydroxyvitamin D3
- 25 Hydroxyvitamin D3
- Calcidiol
- 25-Hydroxycholecalciferol
- 25 Hydroxycholecalciferol
|
Below are MeSH descriptors whose meaning is more general than "Calcifediol".
Below are MeSH descriptors whose meaning is more specific than "Calcifediol".
This graph shows the total number of publications written about "Calcifediol" by people in this website by year, and whether "Calcifediol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcifediol" by people in Profiles.
-
Suppression of Hyperactive Immune Responses Protects against Nitrogen Mustard Injury. J Invest Dermatol. 2015 Dec; 135(12):2971-2981.
-
Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial. Menopause. 2014 Aug; 21(8):823-33.
-
Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J Nutr. 2013 Jan; 143(1):17-26.
-
High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study. Br J Haematol. 2012 Oct; 159(2):211-5.